Uploaded by ayu asan

PHARMA

advertisement
IN GENERAL BEFORE THE ADMINISTRATION
OF ANY ANTIBIOTIC, IT IS CRUCIAL TO
GATHER DATA REGARDING THE HISTORY
OF
OR
SYMPTOMS INDICATIVE OF
HYPERSENSITIVITY
OR
ALLERGIC
REACTIONS."
THAT CATALYZE THE CHEMICAL OPENING
OF THE BETA LACTAM RING
STRUCTURES
IN
BETA
LACTAM
ANTIBIOTICS
ANATOMY PHYSIOLOGY,
PATHOPHYSIOLOGY
OVERVIEW
NURSING PROCESS
ASSESSMENT:
●
●
●
●
●
●
●
"CRUCIAL"
SOMETHING
THAT
CANNOT BE IGNORED
ASSESS
FOR
HISTORY
OF
HYPERSENSITIVITY OR ALLERGIC
REACTIONS
DATA ARE OBTA/NED BEFORE THE
ADMINISTRATION OF THE DRUG.
DETTERMINE
PATIENT'S
AGE
WEIGHT, VITAL SIGNS, LABORATORY
RESULTS
NON
COMPLIANCE
WITH
TREATMENT REGIMEN RELATED TO
LACK OF INFORMATION
DEFICIENT KNOWLEDGE RELATED
TO LACK OF INFORMATION
RISK OF INFECTION RELATED TO
THE
PATIENT'S
POSSIBLE
DEVELOPMENT
OF
A
COMPROMISED IMMUNE STATUS.
EVALUATION
●
●
●
●
●
●
●
●
BACTERIA MAY TAKE NUMBER OF
DIFFERENT
SHAPES
(MORPHOLOGY)
GRAM STAIN PROCEDURE - WAYS
OF CATEGORIZING BACTERIA
PURPLE (GRAM POSITIVE)
RED (GRAM NEGATIVE)
LOOK
FOR
POSITIVE
RESPONSES/THERAPEUTIC
EFFECTS
MONITOR FOR NEGATIVE EFFECTS
EDUCATE THE PATIENT ABOUT THE
EFFECTS
MONITORING OF GOALS, OUTCOME
CRITERIA, THERAPEUTIC EFFECTS
AND ADVERSE EFFECTS
ANTIBIOTICS
HEALTH CARE ASSOCIATED INFECTION
ANTIBIOTIC - HAVING THE ABILITY TO
DESTROY OR INTERFERE WITH THE
DEVELOPMENT OF A LIVING ORGANISM.
(ANTIBACTERIAL)
BETA LACTAM - DESIGNATION OF A BROAD
CLASS OF ANTIBIOTICS THAT INCLUDES
FOUR
SUBCLASSES,;PENICILLINS,
CEPHALOSPORINS, CARBAPENEMS AND
MONOBACTAMS (BETA LACTAM RING)
BETA LACTAMASE - ANY OF A GROUP OF
ENZYMES PRODUCED BY BACTERIA
●
●
COMMUNITY ASSOCIATED
INFECTION
- AN INFECTION THAT IS
ACOUIRED BY A PERSON
WHO HAS NOT RECENTLY
BEEN HOSPITALIZED
NOSOCOMIAL INFECTION
- AN INFECTION THAT A
PATIENT ACQUIRES DURING
THE COURSE OF RECEIVING
TREATMENT FOR ANOTHER
CONDITION IN A HEALTH
CARE FACILITY. ABOVE 48
HRS AFTER ADMISSION
●
●
●
●
●
●
●
●
●
 IRECT CONTACT
D
HANDWASHING: TO PREVENT
SPREAD
DISINFECTANT, ANTISEPTIC
EMPERIC THERAPY
- THE ANTIBIOTIC SELECTED
IS ONE THAT CAN BEST KILL
THE
MICROORGANISM
KNOWN TO BE THE MOST
COMMON CAUSE OF THE
INFECTION
CULTURE AND SENSITIVITY
BROAD SPECTRUM ANTIBIOTIC
NARROW SPECTRUM ANTIBIOTIC
PROPHYLACTIC ANTIBIOTIC
●
●
●
●
-PENICILLINS
CEPHALOSPORINS
- CARBAPENEMS
. MONOBACTAMS
BETA LACTAMASE (BETA LACTAM RING) PIC
PENICILLINS
●
●
●
DERIVED FROM FUNGI OFTEN ON
BREAD OR FRUIT
BACTERICIDAL
ANTIBIOTICS-KILL
WIDE VARIETY OF GRAM + AND
GRAM - BACTERIA.
PENICILLINASES.
THE
BETA
LACTAMASES THAT CAN INACTIVATE
PENICILLIN MOLECULES
BETA LACTAMASE INHIBITORS
●
●
●
CLAVULANIC ACID
TAZOBACTAM
SULBACTAM
SULFONAMIDES
MECHANISM OF ACTION
●
●
ONE OF THE FIRST GROUPS OF
DRUGS USED AS ANTIBIOTICS
SULFAMETHOXAZOLE
COMBINED
WITH TRIMETROPRIN (BACTRIM) OR
SMX-TMP IS COMMONLY USED
CLINICALLY.
MECHANISM OF ACTION
●
●
●
●
●
●
INHIBIT RATHER THAN DESTROY
BACTERIA
BACTERIOSTATIC
ANTIBIOTICS
INHIBIT
THE
GROWTH
OF
SUSCEPTIBLE
BACTERIA
BY
PREVENTING
BACTERIAL
SYNTHESIS OF FOLIC ACID. FOLIC
ACID IS REQUIRED FOR SYNTHESIS
OF PURINES ( DNA,RNA).
COMPETITIVE INHIBITION (PABA,
PTERDINE, GLUTAMIC ACID
INDICATIONS
●
●
●
CONTRAINDICATION
●
●
●
●
DRUGALLERGY TO SULFONAMIDES
PREGNANT WOMEN
INFANTS YOUNGER THAN 2 MONTHS
AGE
INHIBITION OF BACTERIAL CELL
WALL SYNTHESIS.
PENICILLIN BINDING PROTEINS- BY
BINDING WITH THESE PROTEINS
PENICILLINE
INTERFERE
WITH
NORMAL CELL WALL SYNTHESIS.
BACTERIAL
DEATH
LYSIS
(RUPTURE) OF THE BACTERIAL
CELLS
●
GRAM + BACTERIAL INFECTION STREPTOCOCCUS
SP,
ENTEROCOCCUS
SPPSTAPHYLOCOCCUS SPP.
LITTLE ABILITY TO KILL GRAM BACTERIA
EXTENDED
BROAD
SPECTRUM
PENICILLINS:
PIPERACILLIN/TAZOBACTAM
HAVE EXCELLENT GRAM +,GRAM,
ANAEROBIC COVERAGE.
PNEUMONIA
SEPSIS,
INTRAABDOMINAL INFECTION
CONTRAINDICATIONS
BETA LACTAM ANTIBIOTIC
●
BETA LACTAM ANTIBIOTICS
COMMONLY USED DRUGS.
SUBCLASSES:
DRUG ALLERGY
ARE VERY
CEPHALOSPORINS
●
RELATED TO PENICILLINS
●
●
●
BACTERICIDAL AND WORK BY
INTERFERING
WITH
BACTERIAL
CELL WALL SYNTHESIS.
BIND WITH PENICILLIN BINDING
PROTEINS
ACTIVEAGAINTS GRAM +,GRAM - OR
ANAEROBIC BACTERIA
THE LEVEL OF GRAM - COVERAGE
INCREASES WITH EACH SUCCESSIVE
GENERATION.
●
●
●
THE FIRST GENERATION - MOST
GRAM + COVERAGE
LATER GENERATION - MOST GRAM COVERAGE
SECOND AND THIRD GENERATION ANAEROBIC COVERAGE
MONOBACTAMS
●
●
●
●
●
●
AZTEONAM (AZACTAM). IS THE
ONLY MONOBACTAM ANTIBIOTIC TO
BE DEVELOPED SO FAR.
SYNTHETIC BETA LACTAM= ACTIVE
AGAINST
GRAM
AEROBIC
BACTERIA
E COLI, KLEBSIELLASPP,
PSEUDOMONAS SPP
BACTERIDICAL INHIBITS BACTERIAL
CELL WALL SYNTHESIS.
INDICATED
FOR
MODERATELY
SEVERE SYSTEMIC INFECTIONS, UTI
COMMON ADVERSE REACTIONS:
RASH,
NAUSEA,
VOMITING,
DIARRHEA
MACROLIDES
CEFTAROLINE
THE
NEWEST
CEPHALOSPORIN ST GENERATION,COVERS
GRAM +, GRAM - | INCLUDING MRSA
●
●
●
1ST GENERATION:
●
CEFAZOLIN
2ND GENERATION
●
CEFOXITIN, CEFUROXIME
MECHANISM OF ACTION
○
3RD GENERATION
●
CEFTRIAXONE, CEFTAZIDIME
○
4TH GENERATION
●
CEFERIME
5TH GENERATION
●
●
●
●
●
●
●
○
CEFAROLINE
CARBAPENEMS
BROADEST ANTI BACTERIAL ACTION
OF ANY ANTIBITOCS TO DATE.
BACTERICIDAL AND INHIBIT CELL
WALL SYNTHESIS.
RESERVED
FOR
COMPLICATEDBODY CAVITY AND
CONNECTIVE TISSUE
INFECTIONS
ONE HAZARD OF CARBAPENEM USE
IS
DRUG
INDUCED
SEIZURE
ACTIVITY (RARE)
IMIPENEM,CILASTATIN.MEROPENEM.
BACTERIOSTATIC
AZITRHOMYCIN. CLARYTHROMYCIN
ERYTHROMYCIN
AZITHROMYCIN
AND
CLARYTHROMYCIN - WIDELY USED
LONGER DURATION OF CATION,
MILDER GIT ADVERSE EFFECTS
BETTER EFFICACY
INHIBIT PROTEIN SYNTHESIS BY
BINDING REVERSIBLY TO THE 50S
SUBUNITS
OF
SUSCEPTIBLE
MICROORGANISM.
USED FOR UPPER AND LOWER
RESPIRATORY
TRACT
INFECTIONS,SKIN AND SOFT TISSUE
INFECTIONS.
(STREPTOCOCCUS,
HAEMOPHILUS,
SPIROCHETAL
INFECTIONS ETC)
GONOCCOCAL
INFECTIONSIN
COMBINATION
WITH
CEPHALOSPORIN
ANTIBIOTICS FOR RESISTANT INFECTIONS
(HARD TO TREAT)
●
MULTI DRUG RESISTANT
ORGANISMS
ORGANISMS RESISTANT TO ONE OR MORE
CLASSES OF ANTIBIOTICS (MRSA, VRE,
ESBLKPC)
●
●
●
CONTACT
ISOLATION
UNTREATABLE
SPREAD BY CONTACT
PROPER HANDWASHING
PATIENT
AMINOGLYCOSIDES
●
●
●
●
1.
2.
3.
4.
●
●
●
GROUP
OF
NATURAL
AND
SYNTHETIC
ANTIBIOTICS
CLASSIFEID AS BACTERICIDAL.
POTENT ANTIBIOTICS
DRUG OF CHOICE FOR VIRULENT
INFECTIONS
AMKACIN
GENTAMYCIN
TOBRAMYCIN
NOT GIVEN ORALLY-POOR ORAL
ABSORPTION
THERAPEYTIC DRUG MONITORING
(NEPRHOTOXICITY AND
OTOTOXICITY BELOW I MCG/ML)
MECHANISM OF ACTION
●
●
BIND TO RIBOSOMES, PREVENT
PROTEIN SYNTHESIS IN BACTERIA.
OFTEN USED IN COMBINATION WITH
OTHER ANTIBIOTICS SUCHAS BETA
LACTAMS OR VANCOMYCIN IN THE
TREATMENT
OF
VARIOUS
INFECTIONS.
(SYNERGISTIC EFFECT)
➔ BETA LACTAMS ARE GIVEN FIRST
BECAUSE IT BREAKS DOWN THE
BACTERIAL CELL WAL LAND ALLOW
AMINOGLYCOSIDES
TO
GAIN
ACCESS TO RIBOSOMES.
●
●
OTOTOXICITY - NOT REVERSIBLE
DIZZINESS,
TINNITUS, HEARING
LOSS, HEADACHE, PARESTHESIA,
SKIN RASH
NOTE
GENTAMYCIN - THE MOST COMMONLY
USED AMINOGLYCOSIDE CLINICALLY
TODAY
QUINOLONES
○
○
○
○
ALSO KNOWN AS
FLUOROQUINOLONES
VERY
POTENT
BACTERICIDAL
BROAD SPECTRUM ANTIBIOTICS.
NORFLOXACIN,
CIPROFLOXACIN,
LEVOFLOXACIN, MOXIFLOXACIN
EXCELLENT ORAL ABSORPTION
EXCEPT NORFLOXACIN
MECHANISM
●
●
●
●
DESTROL BACTERIA BY ALTERING
THEIR DNA. THEY DO THIS BY
INTERFERING WITH THE BACTERIAL
ENZYMES DNA GYRASE AND TOPOISOMENRASE IV.
GRAM + GRAM - ORGANISMS
SOME QUINOLONES DIFFUSE INTO
HUMAN NEUTROPHILS TO KILL
BACTERIA
SUCHAS
S.AUREUS,
MYCOBACTERIUM FORTUITUM
BACTERIAL RESISTANCE HAS BEEN
IDENTIFIED.
INDICATIONS
●
●
●
●
●
●
●
●
GRAM PSEUDOMONAS
SPR.
ENTEROBACTERIACEAE
(E.
COLI,PROTEUS SPPKLEBSIELLA)
GRAM+
ENTEROCOCCUS
SPP
STAPH
AUREUS,
BACTERIAL
ENDOCARDITIS
USED IN COMBINATION (SYNERGY)
PROPHYLAXIS
PROCEDURES
INVOLVONG GIT,GUT
ADMINISTER
IN
CAUTION
IN
PREMATURE, NEONATES - RENAL
IMMATURITY
SEROUS PEDIATRIC CONDITONS PNEUMONIA, MENINGITIS,UTI
ADVERSE EFFECTS
●
NEPHROTOXICITY - REVERSIBLE
MISCELLANEOUS ANTIBIOTICS
● UNIQUE INDICATIONS, SEPECIALLY
PREFERRED FOR A PARTICULAR
TYPE OF INFECTION
Download